β-elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter

Oncology Reports

Volumn 31, Issue 2, 2014, Pages 858-866

  Guo, Hui Qin ^a,b   Zhang, Guan Nan ^b   Wang, Yi Jun ^b   Zhang, Yun Kai ^b   Sodani, Kamlesh ^b   Talele, Tanaji T ^b   Ashby Jr , Charles R ^b   Chen, Zhe Sheng ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b ST JOHN'S UNIVERSITY   (United States)

Author keywords

elemene; ABCB1; Multidrug resistance

Indexed keywords

BETA ELEMENE; CISPLATIN; COLCHICINE; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; VINBLASTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CURCUMA ZEDOARIA RHIZOME; DRUG BINDING; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG POTENTIATION; DRUG SENSITIVITY; DRUG TRANSPORT; EMBRYO; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDICINAL PLANT; MOLECULAR DOCKING; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RHIZOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BINDING SITES; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; COLCHICINE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; HEK293 CELLS; HUMANS; KB CELLS; MITOXANTRONE; MOLECULAR DOCKING SIMULATION; P-GLYCOPROTEIN; PACLITAXEL; PINELLIA; PLANT EXTRACTS; SESQUITERPENES; VINBLASTINE;

EID: 84892403144     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2870     Document Type: Article

References (43)

1. Gottesman MM and Pastan I : Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993.
2. Goldstein LJ, Gottesman MM and Pastan I: Expression of the MDR1 gene in human cancers. Cancer Treat Res 57: 101-119, 1991.
3. Vasiliou V, Vasiliou K and Nebert DW: Human ATP-binding cassette (ABC) transporter family. Hum Genomics 3: 281-290, 2009.
4. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE and Gottesman MM: P-glycoprotein: from genomics to mechanism. Oncogene 22: 7468-7485, 2003.
5. Perez-Victoria JM, Di Pietro A, Barron D, Ravelo AG, Castanys S and Gamarro F: Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents. Curr Drug Targets 3: 311-333, 2002.
6. Sauna ZE, Kim IW and Ambudkar SV: Genomics and the mechanism of P-glycoprotein (ABCB1). J Bioenerg Biomembr 39: 481-487, 2007.
7. Dean M and Annilo T: Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. Annu Rev Genomics Hum Genet 6: 123-142, 2005.
8. Janssen IJ, Krücken J, Demeler J, Basiaga M, KornáS and von Samson-Himmelstjerna G: Genetic variants and increased expression of Parascaris equorum P-glycoprotein-11 in populations with decreased ivermectin susceptibility. PLoS One 8: e61635, 2013.
9. Shen DW, Lu YG, Chin KV, Pastan I and Gottesman MM: Human hepatocellular carcinoma cell lines exhibit multidrug resistance unrelated to MRD1 gene expression. J Cell Sci 98: 317-322, 1991.
10. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR and Melamed MR: Expression of the multidrug resistance gene product (P -glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38: 1277-1287, 1990.
11. Wu CP, Calcagno AM and Ambudkar SV: Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies. Curr Mol Pharmacol 1: 93-105, 2008.
12. Robert J and Jarry C: Multidrug resistance reversal agents. J Med Chem 46: 4805-4817, 2003.
13. Tan B, Piwnica-Worms D and Ratner L: Multidrug resistance transporters and modulation. Curr Opin Oncol 12: 450-458, 2000.
14. Dantzig AH, de Alwis DP and Burgess M: Considerations in the design and development of transport inhibitors as adjuncts to drug therapy. Adv Drug Deliv Rev 55: 133-150, 2003.
15. Tsuruo T, Iida H, Tsukagoshi S and Sakurai Y: Potentiation of vincristine and adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors. Cancer Res 43: 2267-2272, 1983.
16. de Souza PS, da Cunha Vasconcelos F, Silva LF and Maia RC: Cyclosporine A enables vincristine-induced apoptosis during reversal of multidrug resistance phenotype in chronic myeloid leukemia cells. Tumour Biol 33: 943-956, 2012.
17. Shukla S, Wu CP and Ambudkar SV: Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges. Expert Opin Drug Metab Toxicol 4: 205-223, 2008.
18. Leonard GD, Polgar O and Bates SE: ABC transporters and inhibitors: new targets, new agents. Curr Opin Investig Drugs 3: 1652-1659, 2002.
19. Boesch D, Gavériaux C, Jachez B, Pourtier-Manzanedo A, Bollinger P and Loor F: In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833. Cancer Res 51: 4226-4233, 1991.
20. Germann UA, Shlyakhter D, Mason VS, et al: Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro. Anticancer Drugs 8: 125-140, 1997.
21. Krishna R and Mayer LD: Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 11: 265-283, 2000.
22. Müller H, Pajeva IK, Globisch C and Wiese M: Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors. Bioorg Med Chem 16: 2448-2462, 2008.
23. Morschhauser F, Zinzani PL, Burgess M, Sloots L, Bouafia F and Dumontet C: Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma. Leuk Lymphoma 48: 708-715, 2007.
24. van Zuylen L, Sparreboom A, van der Gaast A, et al: Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933. Eur J Cancer 38: 1090-1099, 2002.
25. Guns ES, Bullock PL, Reimer ML, Dixon R, Bally M and Mayer LD: Assessment of the involvement of CYP3A in the vitro metabolism of a new modulator of MDR in cancer chemotherapy, OC144-193, by human liver microsomes. Eur J Drug Metab Pharmacokinet 26: 273-282, 2001.
26. Zhou HY, Shen JK, Hou JS, Qiu YM and Luo QZ: Experimental study on apoptosis induced by elemene in glioma cells. Ai Zheng 22: 959-963, 2003 (In Chinese).
27. Zou L, Liu W and Yu L: beta-elemene induces apoptosis of K562 leukemia cells. Zhonghua Zhong Liu Za Zhi 23: 196-198, 2001 (In Chinese).
28. Li QQ, Wang G, Zhang M, Cuff CF, Huang L and Reed E: β-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis. Oncol Rep 22: 161-170, 2009.
29. Hu J, Jin W and Yang PM: Reversal of resistance to adriamycin in human breast cancer cell line MCF-7/ADM by β-elemene. Zhonghua Zhong Liu Za Zhi 26: 268-270, 2004 (In Chinese).
30. Biedler JL and Riehm H: Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res 30: 1174-1184, 1970.
31. Juliano RL and Ling V: A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455: 152-162, 1976.
32. Akiyama S, Fojo A, Hanover JA, Pastan I and Gottesman MM: Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Mol Genet 11: 117-126, 1985.
33. Carmichael J, DeGraff WG, Gazdar AF, Minna JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 47: 943-946, 1987.
34. Sodani K, Tiwari AK, Singh S, et al: GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance. Biochem Pharmacol 83: 1613-1622, 2012.
35. Tiwari AK, Sodani K, Dai CL, et al: Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models. Cancer Lett 328: 307-317, 2013.
36. Sun YL, Chen JJ, Kumar P, et al: Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar. PLoS One 8: e55576, 2013.
37. Aller SG, Yu J, Ward A, et al: Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323: 1718-1722, 2009.
38. Shi Z, Tiwari AK, Shukla S, et al: Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance. Cancer Res 71: 3029-3041, 2011.
39. Dai CL, Tiwari AK, Wu CP, et al: Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. Cancer Res 68: 7905-7914, 2008.
40. Ding PR, Tiwari AK, Ohnuma S, et al: The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1/P-glycoprotein transporter. PLoS One 6: e19329, 2011.
41. Huang XC, Sun YL, Salim AA, Chen ZS and Capon RJ: Parguerenes: marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells. Biochem Pharmacol 85: 1257-1268, 2013.
42. Patel A, Tiwari AK, Chufan EE, et al: PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells. Cancer Chemother Pharmacol 72: 189-199, 2013.
43. Xu HB, Li L, Fu J, Mao XP and Xu LZ: Reversion of multidrug resistance in a chemoresistant human breast cancer cell line by β-elemene. Pharmacology 89: 303-312, 2012.